Trichloroethene Exposure and Autoimmune Hepatitis
Trichloroethene Exposure and Autoimmune Hepatitis
批准号:
9333030
负责人:
M. FIROZE KHAN
金额:
$34.88万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-06-01 至 2022-05-31
关键词:
Adoptive TransferAgeAlbuminsAntigen PresentationAntinuclear AntibodiesApoptosisApoptoticAutoantibodiesAutoimmune DiseasesAutoimmune HepatitisAutoimmune ProcessAutoimmunityB-LymphocytesBiological MarkersCD4 Positive T LymphocytesCellsChemical ExposureChemicalsChronicCompetenceDataDendritic CellsDevelopmentDiseaseDoseEarly DiagnosisEnvironmentEnvironmental PollutionExposure toFoundationsGene ProteinsGoalsHealthHelper-Inducer T-LymphocyteHepaticHepatocyteImmunizeImmunoglobulin GIndustrializationInfiltrationInflammationInflammatoryInflammatory ResponseJointsKupffer CellsLinkLiverLymphocyteLymphocyte FunctionLymphocyte SubsetMediatingMicroRNAsModelingModernizationMusNatureNecrosisOccupational ExposureOrganPathogenesisPlasmaPollutionPrevention ResearchPrevention strategyProcessProductionProteinsRegulationResearchRoleSamplingSecondary toSeriesSerumSymptomsT-LymphocyteTestingTherapeutic InterventionToxic effectTranslational ResearchTrichloroethyleneadductattenuationbasecell typediagnostic biomarkerdifferential expressionearly detection biomarkersenvironmental chemicalexperimental studyexposed human populationliver inflammationmolecular diagnosticsnovelplanetary Atmosphere
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract
The long-term goal of our research is to elucidate the mechanisms by which environmental chemicals induce
chronic inflammation that leads to autoimmune diseases, to develop biomarker(s) for early detection of
exposure-related symptoms, to identify targets, and to devise strategies for therapeutic intervention of
environment-linked autoimmune hepatitis (AIH). Using autoimmune-prone MRL+/+ mice, we have shown that
trichloroethene (TCE), an environmental contaminant and widely used industrial chemical, causes chronic
inflammation and AIH. The central hypothesis of this application is that chronic exposure to TCE causes
an imbalance between increased apoptosis and reduced clearance of apoptotic bodies due to
compromised Kupffer cells, leading to T cell-mediated chronic inflammation of the liver (AIH), and that
aberrant regulation of miRNAs contributes to this process. We will test this hypothesis by pursuing three
Specific Aims. Aim 1: Our preliminary data from MRL+/+ mice exposed to TCE indicate that progression to
liver inflammation, autoimmunity, and AIH is preceded by increased apoptosis and accumulation of apoptotic
bodies. Based upon these novel observations, we propose that the delayed clearance of apoptotic bodies
contributes to secondary necrosis, leading to inflammation, autoimmunity and ultimately AIH. This will be
studied thoroughly by evaluating TCE-mediated apoptosis, clearance of apoptotic bodies, functional
competency of Kupffer cells, and characterization of AIH in its progressive development. Aim 2: We have
shown that chronic exposure to TCE results in lymphocyte infiltration into the liver. We will now establish the
contribution of T and B cells to AIH in TCE-exposed MRL+/+ mouse livers by using a series of depletion and
adoptive transfer experiments and functional characterization of lymphocyte subpopulations. To elucidate the
key mechanisms of T helper cell activation and autoantibody production, we will investigate functions of
hepatic dendritic cells in antigen presentation in the liver following TCE exposure. Aim 3: We have
demonstrated a differential expression of mouse liver miRNAs following TCE exposure. To establish their role
in TCE-mediated AIH, we will (a) evaluate the expression of relevant miRNAs in hepatocytes, Kupffer cells,
and lymphocytes isolated from the liver, and (b) induce/inhibit relevant miRNA(s) in these cells from control
and TCE-treated MRL+/+ mice, and correlate the miRNA profile with changes in their downstream targets
associated with apoptosis, inflammation and autoimmunity. Furthermore, plasma samples from mice will also
be screened for relevant miRNAs, since a differential miRNA profile in the plasma has the potential to serve as
a biomarker of AIH. This project will be performed by our existing strong interdisciplinary team and will provide
in-depth mechanistic information on how environmental chemicals contribute to chronic inflammatory diseases
such as AIH.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Unraveling the contribution of gut microbiome in trichloroethene-mediated autoimmunity
-
批准号:10927562
-
项目类别:
-
资助金额:$15.82万
-
财政年份:2023
-
负责人:M. FIROZE KHAN
-
依托单位:
Perchloroethylene Exposure and Autoimmunity
-
批准号:8701671
-
项目类别:
-
资助金额:$17.5万
-
财政年份:2014
-
负责人:M. FIROZE KHAN
-
依托单位:
Oxidative Stress and Autoimmunity
-
批准号:8597487
-
项目类别:
-
资助金额:$22.5万
-
财政年份:2007
-
负责人:M. FIROZE KHAN
-
依托单位:
Oxidative Stress and Autoimmunity
-
批准号:9904620
-
项目类别:
-
资助金额:$32.98万
-
财政年份:2007
-
负责人:M. FIROZE KHAN
-
依托单位:
Oxidative Stress and Autoimmunity
-
批准号:9263612
-
项目类别:
-
资助金额:$34.02万
-
财政年份:2007
-
负责人:M. FIROZE KHAN
-
依托单位:
Oxidative Stress and Autoimmunity
-
批准号:7529873
-
项目类别:
-
资助金额:$32.09万
-
财政年份:2007
-
负责人:M. FIROZE KHAN
-
依托单位:
Oxidative Stress and Autoimmunity
-
批准号:7992428
-
项目类别:
-
资助金额:$31.45万
-
财政年份:2007
-
负责人:M. FIROZE KHAN
-
依托单位:
Oxidative Stress and Autoimmunity
-
批准号:8197373
-
项目类别:
-
资助金额:$31.45万
-
财政年份:2007
-
负责人:M. FIROZE KHAN
-
依托单位:
Oxidative Stress and Autoimmunity
-
批准号:7352908
-
项目类别:
-
资助金额:$32.09万
-
财政年份:2007
-
负责人:M. FIROZE KHAN
-
依托单位:
Xenobiotics, Lipid Peroxidation and Autoimmunity
-
批准号:6855404
-
项目类别:
-
资助金额:$21.02万
-
财政年份:2005
-
负责人:M. FIROZE KHAN
-
依托单位:
Xenobiotics, Lipid Peroxidation and Autoimmunity
-
批准号:6993631
-
项目类别:
-
资助金额:$18.43万
-
财政年份:2005
-
负责人:M. FIROZE KHAN
-
依托单位:
SPLENIC TOXICITY OF ANILINE
-
批准号:6196163
-
项目类别:
-
资助金额:$28.58万
-
财政年份:1994
-
负责人:M. FIROZE KHAN
-
依托单位:
SPLENIC TOXICITY OF ANILINE
-
批准号:6524741
-
项目类别:
-
资助金额:$26.08万
-
财政年份:1994
-
负责人:M. FIROZE KHAN
-
依托单位:
SPLENIC TOXICITY OF ANILINE
-
批准号:6652494
-
项目类别:
-
资助金额:$26.08万
-
财政年份:1994
-
负责人:M. FIROZE KHAN
-
依托单位:
SPLENIC TOXICITY OF ANILINE
-
批准号:2155323
-
项目类别:
-
资助金额:$10.19万
-
财政年份:1994
-
负责人:M. FIROZE KHAN
-
依托单位:
SPLENIC TOXICITY OF ANILINE
-
批准号:2155322
-
项目类别:
-
资助金额:$9.86万
-
财政年份:1994
-
负责人:M. FIROZE KHAN
-
依托单位:
SPLENIC TOXICITY OF ANILINE
-
批准号:2838214
-
项目类别:
-
资助金额:$11.12万
-
财政年份:1994
-
负责人:M. FIROZE KHAN
-
依托单位:
Splenic Toxicity of Aniline
-
批准号:7265211
-
项目类别:
-
资助金额:$34.0万
-
财政年份:1994
-
负责人:M. FIROZE KHAN
-
依托单位:
SPLENIC TOXICITY OF ANILINE
-
批准号:2018463
-
项目类别:
-
资助金额:$10.49万
-
财政年份:1994
-
负责人:M. FIROZE KHAN
-
依托单位:
SPLENIC TOXICITY OF ANILINE
-
批准号:6402604
-
项目类别:
-
资助金额:$26.08万
-
财政年份:1994
-
负责人:M. FIROZE KHAN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: